Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$369K Buy
1,384
+67
+5% +$18.1K ﹤0.01% 530
2025
Q4
$330K Buy
+1,317
New +$350K ﹤0.01% 548
2016
Q2
Sell
-15,497
Closed -$1.56M 690
2016
Q1
$1.56M Buy
+15,497
New +$1.49M 0.01% 396
2015
Q2
Sell
-32,994
Closed -$3.57M 693
2015
Q1
$3.57M Buy
32,994
+5,465
+20% +$562K 0.02% 473
2014
Q4
$2.55M Sell
27,529
-20,893
-43% -$1.85M 0.01% 571
2014
Q3
$4.23M Sell
48,422
-1,106
-2% -$99.9K 0.02% 528
2014
Q2
$4.36M Buy
49,528
+174
+0.4% +$15.1K 0.02% 533
2014
Q1
$4.16M Sell
49,354
-989
-2% -$78.9K 0.02% 530
2013
Q4
$3.95M Sell
50,343
-1,455
-3% -$124K 0.02% 551
2013
Q3
$4.41M Sell
51,798
-1,222
-2% -$103K 0.02% 523
2013
Q2
$4.56M Buy
+53,020
New +$4.4M 0.02% 492

Other funds holding LH

TCW Group's LH Position: Q1 2026 in Review

TCW Group increased its Labcorp (LH) stake by 5.1% in Q1 2026, buying an estimated $18.1K and bringing the position to 1,384 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #530.

TCW Group first reported a position in LH in Q2 2013 and has held it in 11 quarters since. The position peaked at $4.56M in Q2 2013. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • TCW Group held 1,384 shares of Labcorp worth $369K as of Q1 2026.
  • TCW Group bought 67 Labcorp shares in Q1 2026, an estimated $18.1K.
  • Labcorp made up ﹤0.01% of TCW Group's portfolio in Q1 2026, its #530 holding.
  • TCW Group first reported a position in Labcorp in Q2 2013 and has held it in 11 quarters since.
  • TCW Group's Labcorp position peaked at $4.56M in Q2 2013.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.